Judgment of the General Court (Second Chamber) of 25 September 2018.#Amicus Therapeutics UK Ltd and Amicus Therapeutics, Inc. v European Medicines Agency.#Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted as part of the request for authorisation to place the medicinal product Galafold on the market — Decision to grant a third party access to a document — Exception relating to the protection of commercial interests — No general presumption of confidentiality.#Case T-33/17.

Judgment of the General Court (Second Chamber) of 25 September 2018.
Amicus Therapeutics UK Ltd and Amicus Therapeutics, Inc. v European Medicines Agency.
Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted as part of the request for authorisation to place the medicinal product Galafold on the market — Decision to grant a third party access to a document — Exception relating to the protection of commercial interests — No general presumption of confidentiality.
Case T-33/17.

Judgment of the General Court (Second Chamber) of 25 September 2018.
Amicus Therapeutics UK Ltd and Amicus Therapeutics, Inc. v European Medicines Agency.
Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted as part of the request for authorisation to place the medicinal product Galafold on the market — Decision to grant a third party access to a document — Exception relating to the protection of commercial interests — No general presumption of confidentiality.
Case T-33/17.

ECLI identifier: ECLI:EU:T:2018:595